ID

32678

Description

Study ID: 107038 Clinical Study ID: LPL107038 Study Title: Study to Estimate the Dose Proportionality of the Enteric-Coated Freebase Formulation of SB-480848 Patient Level Data:  Clinicaltrials.gov Identifier:  Sponsor: GlaxoSmithKline Collaborators: N/A Phase: Phase 1 Study Recruitment Status: Completed Generic Name: darapladib Trade Name: Tyrisa ,US Study Indication: Atherosclerosis

Keywords

  1. 11/12/18 11/12/18 -
Copyright Holder

GSK group of companies

Uploaded on

November 12, 2018

DOI

To request one please log in.

License

Creative Commons BY-NC 3.0

Model comments :

You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.

Itemgroup comments for :

Item comments for :

In order to download data models you must be logged in. Please log in or register for free.

Estimation of Dose Proportionality of Darapladib - 107038

Administrative Information

Inform Screening
Description

Inform Screening

Subject Initials
Description

Subject Initials

Data type

text

Date of Birth
Description

Date of Birth

Data type

date

Inform Enrolment
Description

Inform Enrolment

Subject Number
Description

Subject Number

Data type

text

Similar models

Administrative Information

Name
Type
Description | Question | Decode (Coded Value)
Data type
Alias
Item Group
Inform Screening
Subject Initials
Item
Subject Initials
text
Date of Birth
Item
Date of Birth
date
Item Group
Inform Enrolment
Subject Number
Item
Subject Number
text

Please use this form for feedback, questions and suggestions for improvements.

Fields marked with * are required.

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial